Effect of Dosing Time and Meal on IN-105 (Insulin Tregopil) PK and PD
NCT03392961
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
51
Enrollment
INDUSTRY
Sponsor class
Conditions
Type 2 Diabetes Mellitus
Interventions
DRUG:
IN-105 (Insulin Tregopil)
OTHER:
Placebo comparator
Sponsor
Biocon Limited